Veteran marketers Amy Houck and Brad Einarsen dive deep into HCP-focused social media

AMM Conversation: Season 4 is exploring "Effective Strategies to Engage Healthcare Professionals (HCPs) Via Social and Multimedia," featuring Erin Fitzgerald, Chief Marketing Officer at Sermo; Dr. Amit Phull, Medical Director and Vice President of Strategy & Insights at Doximity; Laura Nardella, Sales Manager at Reddit, and moderator Ryan Burchinow, Director of Social Media at CMI Media Group.

Episode 4 explores HCP gamification with Dr. Eric Gantwerker, a pediatric otolaryngologist and VP, Medical Director at Level Ex where he leads medical and educational strategy, directs CME and product development, and oversees the physician advisory board. Eric has a Masters in Medical Education from Harvard Medical School and specializes in applying emerging technology to medical education.

Season 4 of the podcast is exploring “Effective Strategies for Engaging Healthcare Professionals Via Social and Multimedia.” Today we have a star-studded group of Pharmaceutical marketers knee deep in social and multimedia. Today's panelists are Ryan Billings, Head of US Oncology Digital Marketing and Customer Experience at Glaxo Smith Kline; Angela Horstmann, US Brand Launch Lead for a Lupus candidate within Immunology Biologics at AstraZeneca, and Paul Murasko, Head of Digital Customer Interaction for North America at Ipsen.

TBA

Season Four of AMM Conversation, the official podcast from the Association of Medical Media, explores “Strategies to Engage Healthcare Professionals via Social and Multimedia.”

Today’s episode of AMM Conversation, the official podcast of the Association of Medical Media, concludes Season Three's exploration of the emerging trends in medical media as we race into 2021 and beyond.

Industry veteran James Brady shares insights on medical media's past, present, and future

TOPIC: Pharma Forecast 2021  LENGTH: 25:43 PANELISTS: Paul Kudlow HOST: Jason E. Carris Today’s episode of AMM Conversation, the official podcast of the Association of Medical Media, continues our exploration of the emerging trends in medical media. Our guest today: Paul Kudlow leads strategic vision at TrendMD. Paul is completing his residency in psychiatry at the University of Toronto. He earned his PhD for research that has advanced the fields of bibliometrics, knowledge dissemination, and scholarly communication.   Topical Timestamps: 1:31  Paul says the pandemic has accelerated the underlying trend of HCP marketing moving more and more to digital programs 3:35  Paul says to think of Pharma marketing as a “decade behind” consumer marketing 9:19  Paul explains why swapping HCP lists weekly is potentially damaging to marketing plans 11:23  The number of interactions needed for a physician to take action or change behavior is exponentially larger than the number of interactions needed for consumers 14:04 Measuring prescription lift with digital marketing is an ongoing challenge 17:05  Paul says a number of scholarly publishers continue to struggle with the shift to digital 23:57 Paul expects Pharma will continue shifting its marketing spend to digital formats in the months and years to come Resources: Find additional medical media resources via AMM's Knowledge Exchange Center. Next: Jim Brady looks back on the most significant changes in Pharmaceutical marketing the past decade — and looks ahead to media trends for 2021. The easiest way to know when the next episode drops is to subscribe or follow the podcast.   Contact us:  AMM Conversation is the official podcast of the Association of Medical Media. Send questions and comments about this podcast series to jcarris525@gmail.com

RJ and Amy provide insights on Pharma's weathering of the pandemic, the emergence of data in HCP marketing, and how eHealthcare Solutions is finding success with native advertising.

Season Three of AMM Conversation, the official podcast of the Association of Medical Media, kicks off with highlights of the AMM Virtual Roundtable that explored what 2021 will hold for Pharma and the emerging trends in  medical media.

Season Three of AMM Conversation dives deep into format and function, everything from programmatic usage and native growth, to traditional best-sellers and the role of multimedia. Join us as we explore how industry leaders are responding to current circumstances and rewriting the rules for HCP engagement and ROI.

TOPIC: The "New Normal" in Medical Media   LENGTH: 44:10 PANELISTS: Eugene Lee and Jim Woodland, CMI/Compas; and Sima Sherman, Sherman Medical Marketing Group  HOST: Jason E. Carris Season Two of the AMM Conversation, the official podcast of the Association of Medical Media, concludes with a final discussion of the "new normal" in medical media. In this episode, we are joined by a trio of medical media experts discussing how the industry is coping, adapting, and excelling during the Covid-19 pandemic. Our panelists today: Eugene Lee, Chief Operating Officer at CMI/Compas, where he is responsible for the global operations of media business leadership, media planning and media strategy disciplines across all clients. Eugene has been with CMI/Compas for over 25 years and is an AMM board member.  Jim Woodland is CMI/Compas' Chief Strategy and Financial Officer. Jim has been the brains behind some of CMI/Compas’ most successful commercial and pricing models in the company’s 30-year history. He has been named to the PharmaVOICE 100 and is a 2020 Philadelphia Business Journal CFO of the year award honoree. Sima Sherman is founder and president of Sherman Medical Marketing Group. A full-service marketing and sales rep firm, Sima works with leading medical publishers and professional societies. She previously was VP of Sales and Marketing with American Medical Communications, and held similar roles with Triple Threat Media. Resources: Find additional medical media resources via AMM's Knowledge Exchange Center. Next: Be on the lookout for Season Three of the podcast this fall. The easiest way to know when the next season drops is to subscribe or follow the podcast.   Contact us:  AMM Conversation is the official podcast of the Association of Medical Media. Send questions and comments about this podcast series to jcarris525@gmail.com.

TOPIC: The New Normal in Medical Media   LENGTH: 35:18 GUEST: Dora Shankman, President & CEO, DPS Strategic Media Enterprises, LLC. HOST: Jason E. Carris   Season Two of the AMM Conversation, the official podcast of the Association of Medical Media, explores the "new normal" in medical media.  In this episode, we are joined by Dora Shankman, a well-known name in healthcare marketing and advertising. Dora discusses how she and her clients are coping, adapting, and excelling during the Covid-19 pandemic. Resources: Find additional medical media resources via AMM's Knowledge Exchange Center. Next:  Ep. 5 will be the final episode of Season Two, and will feature further conversation about the new normal in medical media with Sima Sherman of Sherman Medical Marketing Group, as well as insights from Eugene Lee and Jim Woodland of CMI/Compas.    Contact us:  AMM Conversation is the official podcast of the Association of Medical Media. Send questions and comments about this podcast series to jcarris525@gmail.com.

TOPIC: The New Normal in Medical Media   LENGTH: 35:38 PANELISTS: Benji Kayne, MedscapeLive! HOST: Jason E. Carris Season Two of the AMM Conversation, the official podcast of the Association of Medical Media, explores the "new normal" in medical media.  In this episode, we are discussing how the industry is coping, adapting, and excelling during the Covid-19 pandemic.  Our guest is Benji Kayne, Vice President of Experiential and Learning Events at MedscapeLive!. Benji joined MedscapeLive! in February, having previously produced events for Google. With the rapid onset of the pandemic, the MedscapeLive! team deftly pivoted more than 150 in-person experiences to an all-virtual events platform in a matter of weeks. Listen in as Benji discusses the challenges and successes of producing medical events in the virtual space. Resources:  Find additional medical media resources via AMM's Knowledge Exchange Center. Next:  Ep. 4 features further conversation about the new normal in medical media with industry veteran Dora Shankman, President and CEO of Shankman Marketing and Media Resources.    Contact us:  AMM Conversation is the official podcast of the Association of Medical Media. Send questions and comments about this podcast series to jcarris525@gmail.com.

TOPIC: The New Normal in Medical Media   LENGTH: 41:26 PANELISTS: Denis Conlon, Alejandro Alvarez, and Sumner Mering of Elsevier's Global Commercial Sales and Marketing Group  HOST: Jason E. Carris Season Two of the AMM Conversation, the official podcast of the Association of Medical Media, explores the "new normal" in medical media.  In this episode, we are joined by a trio of medical media experts discussing how the industry is coping, adapting, and excelling during the Covid-19 pandemic. Our panelists today are from Elsevier:  Denis Conlon is VP of Marketing for Elsevier's Global Commercial Sales and Marketing Group;  Alejandro Alvarez is Director of Business Development and Strategic Partnerships Sumner Mering is a veteran in medical media and one of the group's Directors of Commercial Sales Resources: Find additional medical media resources via AMM's Knowledge Exchange Center. Next:  Ep. 3 features further conversation about the new normal in medical media with MedScapeLive!'s VP of Experiential and Learning Events Benji Kayne.    Contact us:  AMM Conversation is the official podcast of the Association of Medical Media. Send questions and comments about this podcast series to jcarris525@gmail.com.

TOPIC: The New Normal in Medical Media   LENGTH: 28:12 PANELISTS: Matthew Holland, John C. Carter, Joan-Marie Stiglich HOST: Jason E. Carris Season Two of the AMM Conversation, the official podcast of the Association of Medical Media, explores the "new normal" in medical media. In this episode, we are joined by a trio of medical publishing experts discussing how the industry is coping, adapting, and excelling during the Covid-19 pandemic.  Our panelists today are from Healio and its parent company, The Wyanoke Group:  John C. Carter is Chief Operating Officer of The Wyanoke Group. Healio, Healio Strategic Solutions, Healio Live and SLACK Incorporated are wholly owned subsidiaries of The Wyanoke Group. John has been with the company since 1982. Joan-Marie Stiglich is Chief Content Officer at Healio and a 25-year veteran of medical publishing. She has spent the duration of her career at the company. Matthew Holland is Chief Commercial Officer of Healio Strategic Solutions, where he is responsible for all print, digital and custom sales operations. Resources: Find additional medical media resources via AMM's Knowledge Exchange Center. Next:  Ep. 2 features further conversation about the new normal in medical media with Denis Conlon, Sumner Mering, and Alejandro Alvarez from Elsevier's Global Commercial Sales and Marketing Group.    Contact us:  AMM Conversation is the official podcast of the Association of Medical Media. Send questions and comments about this podcast series to jcarris525@gmail.com.

Welcome to AMM Conversation, the official podcast of the Association of Medical Media (ammonline.org). Season Two explores the "new normal" in medical media, as the industry copes, adapts, and excels in the face of the global health crisis. Guests this season include Healio's Matt Holland and JoanMarie Stiglich, Elsevier's Denis Conlon and Alejandro Alvarez, and Kantar's David Emery. Listen weekly via Apple Podcasts, Spotify, Google Podcasts, Stitcher, or wherever you enjoy podcasts.

Dr. Augustine Fou, formerly the Chief Digital Office at Omnicom and a recognized ad fraud expert, joins the AMM Conversation as we wrap up our exploration of data privacy and medical media. An MIT-trained scientist who has more than two decades of experience working with healthcare clients, Dr. Fou has taught digital strategy at NYU and Rutgers. His clients run the gamut of marketers, publishers, and ad tech firms. Dr. Fou said he considers 2020 a transition year for data privacy, with regulators taking notice that privacy issues should be taken more seriously. As consumers better understand the ways their data is being used and abused, he says government will move to, at least, “put guard rails around data privacy.”

As big data and data security have grown in the past decade, the federal government has been “reluctant to get involved,” says Jon Bigelow, past president and current board member of the Association of Medical Media. He says many of the companies involved in data are monopolies, yet the government has “not taken the same anti-trust stance as it did previously with Standard Oil, the railroads, or Bell breakups.”